Aseptic meningitis associated with muromonab CD3 administration. 1989

J D Sutton, and M H Prioleau, and C J Wordell, and G C Francos

UI MeSH Term Description Entries
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D008582 Meningitis, Aseptic A syndrome characterized by headache, neck stiffness, low grade fever, and CSF lymphocytic pleocytosis in the absence of an acute bacterial pathogen. Viral meningitis is the most frequent cause although MYCOPLASMA INFECTIONS; RICKETTSIA INFECTIONS; diagnostic or therapeutic procedures; NEOPLASTIC PROCESSES; septic perimeningeal foci; and other conditions may result in this syndrome. (From Adams et al., Principles of Neurology, 6th ed, p745) Aseptic Meningitis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D016853 Muromonab-CD3 Anti-CD3 monoclonal antibody that exerts immunosuppressive effects by inducing peripheral T-cell depletion and modulation of the T-cell receptor complex (CD3/Ti). Monoclonal Antibody OKT3,OKT3,Orthoclone OKT3,Muromonab CD3

Related Publications

J D Sutton, and M H Prioleau, and C J Wordell, and G C Francos
December 1990, DICP : the annals of pharmacotherapy,
J D Sutton, and M H Prioleau, and C J Wordell, and G C Francos
December 1991, DICP : the annals of pharmacotherapy,
J D Sutton, and M H Prioleau, and C J Wordell, and G C Francos
October 1988, Clinical pharmacy,
J D Sutton, and M H Prioleau, and C J Wordell, and G C Francos
September 1989, DICP : the annals of pharmacotherapy,
J D Sutton, and M H Prioleau, and C J Wordell, and G C Francos
February 1991, DICP : the annals of pharmacotherapy,
J D Sutton, and M H Prioleau, and C J Wordell, and G C Francos
August 1993, Clinical pharmacy,
J D Sutton, and M H Prioleau, and C J Wordell, and G C Francos
December 1988, Clinical pharmacy,
J D Sutton, and M H Prioleau, and C J Wordell, and G C Francos
May 2005, Nihon rinsho. Japanese journal of clinical medicine,
J D Sutton, and M H Prioleau, and C J Wordell, and G C Francos
June 1991, The Australian nurses' journal. Royal Australian Nursing Federation,
J D Sutton, and M H Prioleau, and C J Wordell, and G C Francos
February 1989, The Journal of infectious diseases,
Copied contents to your clipboard!